Logotype for Wave Life Sciences Ltd

Wave Life Sciences (WVE) investor relations material

Wave Life Sciences Chardan’s 9th Annual Genetic Medicines Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Wave Life Sciences Ltd
Chardan’s 9th Annual Genetic Medicines Conference summary21 Oct, 2025

Advances in ADAR RNA editing and clinical translation

  • ADAR RNA editing is progressing from theoretical and preclinical stages to clinical proof, with human data now demonstrating effective mutation correction and protein restoration in alpha-1 antitrypsin deficiency (AATD).

  • Clinical data show that editing can shift patients from a high-risk ZZ phenotype to a lower-risk MZ phenotype, with durable increases in functional protein and reduction in disease-driving variants.

  • Editing approaches using GalNAc conjugation enable stable, durable, and efficient delivery, with ongoing studies exploring higher doses and less frequent dosing intervals.

  • Regulatory approval thresholds are being defined by phenotypic outcomes and biomarker levels, with acute phase response data supporting clinical benefit.

  • The field is rapidly learning from clinical translation, using human data to refine preclinical models and accelerate new target development.

Platform innovation and pipeline expansion

  • Companies are leveraging foundational research to optimize oligonucleotide chemistry and engage multiple ADAR isoforms, supporting robust and durable editing.

  • Preclinical data show high levels of target protein restoration and long half-lives, supporting less frequent dosing and broadening the range of treatable liver diseases.

  • New targets beyond AATD, such as PNPLA3 for liver disease and NTCP for cholestatic disease, are entering clinical and preclinical pipelines, with strategies tailored to genetic and mechanistic insights.

  • CNS applications are advancing, with strong endogenous ADAR expression and efficient oligonucleotide distribution demonstrated in preclinical models.

  • Companies are focusing on precision edits, such as modulating protein-protein interactions, and identifying white space in the liver for future indications.

Industry perspectives and future outlook

  • The field is converging on the use of GalNAc for liver delivery, with consensus that editing offers unique advantages over knockdown approaches.

  • Key to broader adoption is understanding enzyme pharmacology and translation from animal models to humans, with confidence growing in ADAR's therapeutic reliability.

  • Investment and regulatory focus is shifting from enzyme function to target selection and clinical proof of concept, with expectations for rapid progress based on validated chemical toolboxes.

  • The technology is expected to evolve quickly, with first-generation drugs paving the way for more optimized future candidates.

  • The panel anticipates that RNA editing will reach broad applicability faster than previous modalities, driven by clinical learnings and platform advances.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Wave Life Sciences earnings date

Logotype for Wave Life Sciences Ltd
Status Update29 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Wave Life Sciences earnings date

Logotype for Wave Life Sciences Ltd
Status Update29 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Wave Life Sciences Ltd. (WVE) is a biotechnology company leveraging its proprietary RNA medicines platform, PRISM, to develop transformative treatments for a range of genetic diseases. This platform enables the design, optimization, and production of novel stereopure oligonucleotides, aimed at correcting disease-causing mutations, modulating protein activity, and restoring functional protein production or reducing disease-promoting RNAs or proteins. Wave's diverse pipeline includes clinical programs targeting Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency, Huntington's disease, and a preclinical program for obesity, among others. Their approach includes multiple RNA-targeting modalities such as editing, splicing, RNA interference, and antisense silencing, showcasing their broad capabilities in addressing complex disease biology. The company is headquartered in Singapore, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage